Prospective Evaluation of Aspergillus fumigatus-Specific IgG in Patients With Cystic Fibrosis

by Patience Eschenhagen, Claudia Grehn, Carsten Schwarz
Published 2021-01-01

Mutation on lysX from Mycobacterium avium hominissuis impacts the host–pathogen interaction and virulence phenotype

by Greana Kirubakar, Hubert Schäfer, Volker Rickerts, Carsten Schwarz, Astrid Lewin
Published 2020-01-01

Urban Life as Risk Factor for Aspergillosis

by Claudia Grehn, Patience Eschenhagen, Svenja Temming, Uta Düesberg, Konrad Neumann, Carsten Schwarz
Published 2020-11-01

Frequent Pet Contact as Risk Factor for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis

by Claudia Grehn, Patience Eschenhagen, Svenja Temming, Uta Düesberg, Konrad Neumann, Carsten Schwarz
Published 2021-01-01

Impact of Long-Term Tiotropium Bromide Therapy on Annual Lung Function Decline in Adult Patients with Cystic Fibrosis.

by Claudia Brandt, Anja Thronicke, Jobst F Roehmel, Alexander Krannich, Doris Staab, Carsten Schwarz
Published 2016-01-01

Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic Fibrosis

by Patrick O. Hanafin, Isabelle Sermet-Gaudelus, Matthias Griese, Matthias Kappler, Helmut Ellemunter, Carsten Schwarz, Carsten Schwarz, John Wilson, John Wilson, Marsha Tan, Tony Velkov, Gauri G. Rao, Elena K. Schneider-Futschik
Published 2021-08-01

Biatrial Remodeling in Patients with Cystic Fibrosis Running Title: Atrial Function in Cystic Fibrosis

by Aleksandar Dordevic, Martin Genger, Carsten Schwarz, Cesare Cuspidi, Elvis Tahirovic, Burkert Pieske, Hans-Dirk Düngen, Marijana Tadic
Published 2019-07-01

Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary infection

by James Greenwood, Carsten Schwarz, Urte Sommerwerck, Edward F Nash, Michael Tamm, Weihua Cao, Paul Mastoridis, Laurie Debonnett, Kamal Hamed
Published 2017-07-01

Prospective multicenter German study on pulmonary colonization with Scedosporium /Lomentospora species in cystic fibrosis: Epidemiology and new association factors.

by Carsten Schwarz, Claudia Brandt, Elisabeth Antweiler, Alexander Krannich, Doris Staab, Sabina Schmitt-Grohé, Rainald Fischer, Dominik Hartl, Anja Thronicke, Kathrin Tintelnot
Published 2017-01-01

Genetic diversification of persistent Mycobacterium abscessus within cystic fibrosis patients

by Astrid Lewin, Elisabeth Kamal, Torsten Semmler, Katja Winter, Sandra Kaiser, Hubert Schäfer, Lei Mao, Patience Eschenhagen, Claudia Grehn, Jennifer Bender, Carsten Schwarz
Published 2021-01-01

Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b study

by Silke van Koningsbruggen-Rietschel, Jane C. Davies, Tacjana Pressler, Rainald Fischer, Gordon MacGregor, Scott H. Donaldson, Knut Smerud, Nils Meland, Jann Mortensen, Marie Ø. Fosbøl, Damian G. Downey, Astrid H. Myrset, Hugo Flaten, Philip D. Rye, The following investigators and their teams (in alphabetical order) conducted this study., Mary Carroll, Jane Davies, Carsten Schwarz, Nico Derichs, Damian Downey, Olaf Eickmeier, Pal Leyell Finstad, Marie Øbro Fossbøl, Marita Gilljam, Lena Hjelte, Alan Knox, Silke van Koningsbruggen-Rietschel, Gordon MacGregor, Jann Mortensen, Susanne Nährig, Tacjana Pressler, Joachim Riethmüller, Felix C. Ringshausen, Hugo Flaten, AS AlgiPharma, Laura Gow, Joy Conway, Jann Mortensen, Scott H. Donaldson, William Bennett
Published 2020-10-01